Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Bai Fu Zi is a traditional herbal medicine derived from the dried tuber of *Typhonium giganteum* Engl. Produced by the Vietnamese pharmaceutical company Mediplantex (Mediplantex National Pharmaceutical JSC), it is a staple of traditional Vietnamese (Đông y) and Chinese medicine. It is traditionally indicated for the treatment of 'wind-phlegm' disorders, which include conditions such as facial nerve paralysis (Bell's palsy), stroke-related speech impairment, migraines, and certain skin conditions. The herb is known for its ability to dispel wind, resolve phlegm, and alleviate spasms. As a traditional herbal preparation, it is typically processed to reduce its natural toxicity before being administered in oral forms such as decoctions, powders, or tablets. Mediplantex markets this product as part of its traditional medicine portfolio rather than through a modern biotech R&D pipeline.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Bai Fu Zi.